Abstract: The invention provides compounds of the formula (I): The compounds have activity against cyclin dependent kinases, glycogen synthase kinase and Auroa kinases and are therefore useful to treat cancer and viral diseases.
Type:
Application
Filed:
July 4, 2004
Publication date:
May 10, 2007
Applicant:
Atex Therapeutics, Limited
Inventors:
Valerio Berdini, Andrew Woodhead, Paul Wyatt, Michael O'Brien, Eva Navarro